Q2 EPS Forecast for Revolution Medicines Lowered by Analyst
Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) – Equities research analysts at HC Wainwright dropped their Q2 2025 earnings per share (EPS) estimates for shares of Revolution Medicines in a research note issued on Wednesday, May 14th. HC Wainwright analyst R. Burns now expects that the company will post earnings of ($1.15) per share for […]
Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) – Equities research analysts at HC Wainwright dropped their Q2 2025 earnings per share (EPS) estimates for shares of Revolution Medicines in a research note issued on Wednesday, May 14th. HC Wainwright analyst R. Burns now expects that the company will post earnings of ($1.15) per share for […]
